These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 27400657)

  • 41. Implementation of a home-based colorectal cancer screening intervention in Malaysia (CRC-SIM).
    Schliemann D; Ramanathan K; Ibrahim Tamin NSB; O'Neill C; Cardwell CR; Ismail R; Kassim Z; Kee F; Su TT; Donnelly M
    BMC Cancer; 2023 Jan; 23(1):22. PubMed ID: 36609260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for colorectal cancer by immunochemical fecal occult blood testing.
    Saito H
    Jpn J Cancer Res; 1996 Oct; 87(10):1011-24. PubMed ID: 8957057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opportunistic screening for colorectal neoplasia in Singapore using faecal immunochemical occult blood test.
    Tan WS; Tang CL; Koo WH
    Singapore Med J; 2013 Apr; 54(4):220-3. PubMed ID: 23624450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High sensitivity of five colorectal screening programmes with faecal immunochemical test in the Veneto Region, Italy.
    Zorzi M; Fedato C; Grazzini G; Stocco FC; Banovich F; Bortoli A; Cazzola L; Montaguti A; Moretto T; Zappa M; Vettorazzi M
    Gut; 2011 Jul; 60(7):944-9. PubMed ID: 21193461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.
    Ibañez-Sanz G; Garcia M; Milà N; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Benito L; Padrol I; Barenys M; Moreno V
    Eur J Cancer Prev; 2017 Sep; 26(5):365-367. PubMed ID: 27433880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk stratification and detection of new colorectal neoplasms after colorectal cancer screening with faecal occult blood test: experiences from a Danish screening cohort.
    Bjerrum A; Milter MC; Andersen O; Fischer A; Lynge E
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1433-7. PubMed ID: 26352132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic yield of a one sample immunochemical test at different cut-off values in an organised screening programme for colorectal cancer.
    Hamza S; Dancourt V; Lejeune C; Bidan JM; Lepage C; Faivre J
    Eur J Cancer; 2013 Aug; 49(12):2727-33. PubMed ID: 23601670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cost-effectiveness of immunochemical tests for colorectal cancer screening.
    Lejeune C; Le Gleut K; Cottet V; Galimard C; Durand G; Dancourt V; Faivre J
    Dig Liver Dis; 2014 Jan; 46(1):76-81. PubMed ID: 24012177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for colorectal cancer with immunochemical faecal occult blood tests.
    Faivre J; Dancourt V; Lejeune C
    Dig Liver Dis; 2012 Dec; 44(12):967-73. PubMed ID: 22898146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer.
    Juul JS; Hornung N; Andersen B; Laurberg S; Olesen F; Vedsted P
    Br J Cancer; 2018 Aug; 119(4):471-479. PubMed ID: 30065255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
    Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
    Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.
    Rigter LS; Spaander MC; Moons LM; Bisseling TM; Aleman BM; de Boer JP; Lugtenburg PJ; Janus CP; Petersen EJ; Roesink JM; Raemaekers JM; van der Maazen RW; Cats A; Bleiker EM; Snaebjornsson P; Carvalho B; Lansdorp-Vogelaar I; Jóźwiak K; Te Riele H; Meijer GA; van Leeuwen FE; van Leerdam ME
    BMC Cancer; 2017 Feb; 17(1):112. PubMed ID: 28173773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delayed sample arrival at the laboratory does not lead to more false negatives in the Danish population screening for colorectal cancer.
    Hansen AT; Hoffmann-Lücke E; Nielsen BK; Reinholdt B; Hindersson P; Heidemann K; Hornung N
    Scand J Clin Lab Invest; 2017 Dec; 77(8):685-688. PubMed ID: 28933963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
    Li S; Wang H; Hu J; Li N; Liu Y; Wu Z; Zheng Y; Wang H; Wu K; Ye H; Rao J
    Int J Cancer; 2006 Jun; 118(12):3078-83. PubMed ID: 16425283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Few complications, but only little effect on cancer related death by screening colonoscopy].
    Holst LL; Andersen O; Fischer TK
    Ugeskr Laeger; 2013 Aug; 175(33):1852-5. PubMed ID: 23937871
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
    Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
    PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.